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Research
Correspondence A Bi-Center Cardiovascular Magnetic Resonance
Prognosis Study Focusing on Dobutamine
Wall Motion and Late Gadolinium Enhancement in
3,138 Consecutive PatientsTo the Editor: In the present study we sought to investigate the
predictive value of resting and inducible wall motion abnormalities
(WMA) and of late gadolinium enhancement (LGE) for hard
cardiac outcomes and for revascularization procedures in 3,138
patients undergoing dobutamine cardiac magnetic resonance
(DCMR) in 2 tertiary centers (University Hospital Heidelberg;
and German Heart Institute, Berlin) and during a long-term
follow-up.
From January 2000 through June 2008, consecutive patients
who were referred for clinically indicated DCMR due to suspected
or known coronary artery disease were prospectively enrolled. Our
patient cohort consisted of 1,369 patients enrolled in Berlin and
1,493 patients enrolled in Heidelberg who were reported in
previous studies (1,2). Additional patients (n 276) were added in
he present analysis, resulting in 3,138 patients in the analysis
opulation. Patients were examined in clinical 1.5-T whole-body
ardiac magnetic resonance scanners. Wall motion and LGE
maging were performed and interpreted as described previously
1,2). Patient preparation, imaging and analysis for DCMR
mounted to approximately 30 to 40 min.
Cardiac death and nonfatal myocardial infarction were regis-
ered as hard cardiac events. Other events included clinically
ndicated revascularization by percutaneous coronary intervention
PCI) or coronary artery bypass graft (CABG). Because the results
f the magnetic resonance examination might have triggered
evascularization procedures, patients with “early” revascularization
rocedures within 3 months after DCMR were censored. A
eparate analysis was performed in this patient subgroup, to
nvestigate the effect of early revascularization procedures on
ubsequent cardiac events.
Data were collected in 3,138 patients during a 3.3  1.7-year
range 0.5 to 9.7-year) follow-up period. Hard cardiac events
ccurred in 183 (5.8%) patients, including 80 (2.5%) cardiac deaths
n  44 due to intractable heart failure, n  21 due to infarction,
nd n  15 who died suddenly) and 103 (3.3%) nonfatal
yocardial infarctions. In 520 (16.6%) patients early revascular-
zation was performed within 90 days after the magnetic resonance
xamination (450 by PCI, and 70 by CABG), and 257 (8.2%)
atients underwent late revascularization (203 by PCI, and 54 by
ABG). Noncardiac death was recorded in 43 (1.4%) patients.
By multivariable analysis, inducible WMA, LGE, and resting
MA were independent predictors of hard cardiac events (hazard
atio [HR]: 6.5, 95% confidence interval [CI]: 4.6 to 9.3; HR: 2.2,
5% CI: 1.2 to 4.1; and HR: 1.6, 95% CI: 1.2 to 2.3, respectively,
 0.001 for all). With a series of Cox proportional hazards
odels, resting and inducible WMA exhibited incremental valuebeyond clinical parameters for the prediction of outcome (Fig. 1A).
In patients where LGE was additionally performed, resting
WMA, LGE, and inducible WMA exhibited incremental value
(Fig. 1B). With integrated discrimination improvement analysis,
inducible WMA exhibited incremental value in the first model,
whereas LGE and inducible WMA showed incremental value in
the second model (Figs. 1A and 1B).
Patients with inducible WMA experienced a significantly
higher rate of hard cardiac events (Fig. 1C), whereas patients with
LGE exhibited a higher rate of subsequent hard cardiac events
compared with those without LGE (Fig. 1D). In the absence of
inducible ischemia by DCMR, clinical outcomes were not influ-
enced either by PCI or CABG (Fig. 1E). Conversely, patients
with inducible WMA equally profited from PCI and CABG
compared with those continued on medical treatment (Fig. 1F).
Within the first 3 years of follow-up excellent outcomes were
recorded for patients without inducible ischemia with regard to
hard cardiac events and late revascularization procedures (annual
hard event rate of 0.6%, and revascularization rate of 1.6%).
Between the third and fourth year, however, hard cardiac event
rates increased by 2-fold (from 0.9% to 2.0%). Over the third and
sixth year, annual event rates rose for both hard events and
revascularization to 1.6% and 3.2%, respectively.
Our DCMR findings in 3,138 patients demonstrate that:
1. The presence of inducible WMA and LGE independently
identify patients at increased risk for subsequent cardiac
events;
2. Only patients with inducible ischemia benefit from revascu-
larization procedures (PCI and CABG);
3. Excellent risk prediction extends up to 3 years after the initial
diagnostic procedure, whereas repeated testing might be
warranted after this time period due to a subsequent rise
(2-fold rise between the third and fourth year) in the annual
event rates.
The assessment of myocardial perfusion during vasodilator
stress with adenosine or dipyridamole was shown to be a strong
predictor of hard cardiac events in several studies, which included
patients with stable angina (3–8). A number of further studies
demonstrated the value of wall motion assessment during inotropic
stimulation with dobutamine for the prediction of cardiac events
(1,2,4,9,10). Hereby, it should be noted that the mean follow-up
duration was lower in previous studies (2.2 years vs. 3.3 years in our
study), whereas the total number of hard cardiac events was lower
than that observed in our population (142 in all previous studies vs.
183 in our study). Furthermore, although the complementary value
2311JACC Vol. 61, No. 22, 2013 Correspondence
June 4, 2013:2310–7of LGE was previously demonstrated for myocardial perfusion
analysis during vasodilator stress (8), no published report investi-
gated the role of LGE with DCMR in this context so far.
In our study, we demonstrate the incremental value of LGE and
Figure 1 Cox Proportional Hazards Models and Survival Analysis
In a series of Cox models evaluated for the prediction of hard cardiac events clinic
incremental prognostic information to the model (A). In patients where late gadoli
cal parameters and resting WMA for the prediction of outcome (B). Patients with i
patients with LGE showed a higher rate of subsequent hard cardiac events (D). In
by percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
with those continued on medical treatment (F).inducible WMA for the assessment of long-term prognosis in thelargest patient cohort thus far. Inducible WMA and LGE pro-
vided the highest HRs for future hard cardiac events, surpassing
that provided by clinical parameters. Patients without inducible
WMA yielded excellent prognosis within the first 3 years of
factors, resting, and inducible wall motion abnormality (WMA), each offered
nhancement (LGE) was performed, LGE exhibited incremental value beyond clini-
le WMA exhibited a significantly higher rate of hard cardiac events (C), whereas
sence of inducible ischemia (IDI), clinical outcomes were not influenced either
onversely, patients with inducible WMA profited from PCI and CABG comparedal risk
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June 4, 2013:2310–7However, the annual event rate rose after the first 3 years,
indicating that in patients with persistent or recurrent stable chest
pain syndrome and initially negative stress testing, repeated
DCMR diagnostic procedures might be warranted.
Furthermore, early revascularization either by PCI or CABG
both improved clinical outcome only in patients with inducible
WMA by DCMR, whereas patients who underwent revascular-
ization in the absence of inducible ischemia showed no significant
benefit from invasive treatment. This is in agreement with recent
randomized multicenter trials, where only patients with ischemia
benefited from invasive procedures (11,12).
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Letters to the Editor
Long-Term Survival of Young
Patients With Coronary Artery
Disease Is Best Realized Through
Surgical Revascularization
With Mammary Arteries
In a recent issue of the Journal, Flather et al. (1) reported a
subgroup analysis of individual patient data from 10 randomized
trials comparing percutaneous coronary intervention (PCI) and
coronary artery bypass grafting (CABG) for multivessel coronary
disease. Their analysis showed that there was a significant treat-
ment by age interaction for 10-year mortality (p  0.001).
Strikingly enough, in the youngest group of patients (56.2 years
of age), there was no difference in mortality (hazard ratio [HR] for
PCI: 1.23; 95% CI: 0.95 to 1.59), whereas the HR shifted toward
a significant benefit of CABG over PCI in older patients (65.2
years of age) (HR: 0.79; 95% CI: 0.67 to 0.94).
Although the data from these trials are compelling, the trials
were not performed according to the “all-comers” design, and it is
therefore likely that there was a severe selection bias in the
inclusion of patients. Young patients were probably those with low
lesion complexity, and it is known that CABG does not offer a
survival benefit in these patients (2). In contrast, even though the
